Clotrimazole/betamethasone dipropionate
| Combination of | |
|---|---|
| Clotrimazole | Azole antifungal |
| Betamethasone dipropionate | Corticosteroid |
| Names | |
| Trade names | Lotrisone |
| Clinical data | |
| Routes of use | Topical |
| External links | |
| AHFS/Drugs.com | Professional Drug Facts |
| Legal | |
| License data | |
| Legal status |
|
| Identifiers | |
| CAS Number |
|
| UNII | |
| KEGG | |
| ATC code | |
Clotrimazole/betamethasone dipropionate, sold under the brand name Lotrisone among others, is a topical medication for the treatment of fungal infections of the feet, groin, and body in people 17 years of age and older.[1] It is a combination of clotrimazole and betamethasone dipropionate.[1] It is applied to the skin.[1]
Common side effects include paresthesia, rash, edema, and secondary infections.[1]
In 2017, it was the 300th most commonly prescribed medication in the United States, with more than one million prescriptions.[2][3]
Medical uses
Clotrimazole/betamethasone dipropionate is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to Epidermophyton floccosum, Trichophyton mentagrophytes, and Trichophyton rubrum in people 17 years of age and older.[1]
History
Clotrimazole/betamethasone dipropionate cream was approved for use in the United States in July 1984,[4] and the lotion was approved for use in the United States in December 2000.[5]
Society and culture
Cost
In 2017, it was the 300th most commonly prescribed medication in the United States, with more than one million prescriptions.[2][3]
-
Betamethasone Dipropionate/Clotrimazole costs (US)
-
Betamethasone Dipropionate/Clotrimazole prescriptions (US)
.svg)
.svg)
References
- ↑ 1.0 1.1 1.2 1.3 1.4 "Lotrisone- clotrimazole and betamethasone dipropionate cream". DailyMed. 14 June 2019. Archived from the original on 28 August 2021. Retrieved 13 April 2020.
- ↑ 2.0 2.1 "The Top 300 of 2020". ClinCalc. Archived from the original on 12 February 2021. Retrieved 11 April 2020.
- ↑ 3.0 3.1 "Betamethasone Dipropionate; Clotrimazole - Drug Usage Statistics". ClinCalc. 23 December 2019. Archived from the original on 12 April 2020. Retrieved 11 April 2020.
- ↑ "Lotrisone: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Archived from the original on 1 October 2020. Retrieved 13 April 2020.
- ↑ "Drug Approval Package: Lotrisone (Clotrizazole & Betamethasone Dipropionate) NDA #020010". U.S. Food and Drug Administration (FDA). 8 September 2004. Archived from the original on 7 April 2021. Retrieved 13 April 2020.
External links
- "Betamethasone dipropionate mixture with Clotrimazole". Drug Information Portal. U.S. National Library of Medicine. Archived from the original on 28 August 2021. Retrieved 13 January 2021.
- "Betamethasone Topical: MedlinePlus Drug Information". MedlinePlus. Archived from the original on 29 March 2020. Retrieved 13 January 2021.
- "Clotrimazole Topical: MedlinePlus Drug Information". MedlinePlus. Archived from the original on 24 January 2021. Retrieved 13 January 2021.
 | This dermatologic drug article is a stub. You can help MDWiki by expanding it. |
- Pages using duplicate arguments in template calls
- Use dmy dates from April 2020
- Articles with invalid date parameter in template
- Drugs with non-standard legal status
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Multiple chemicals in Infobox drug
- Multiple chemicals in an infobox that need indexing
- Chemical articles with multiple CAS registry numbers
- Articles containing unverified chemical infoboxes
- Drugs that are a combination of chemicals
- Portal templates with all redlinked portals
- Combination drugs
- Corticosteroids
- Imidazole antifungals
- All stub articles
- Dermatologic drug stubs